Investigating seizures in bariatric surgery patients: Pre- and postoperative perspectives: A systematic review.

Matin Bidares, Mahsa Aziz, Sara Samadzadeh, Ramtin Bidares, Sjaak Pouwels, Suhaib J S Ahmad, Carolina Pape-Köhler

Journal: Obesity pillars 2026;20():100326

PMID: 42799053

Abstract

BACKGROUND

Bariatric surgery is widely used for severe obesity and may influence neurological outcomes through metabolic alterations, nutritional deficiencies, and changes in Antiepileptic Drug (AED) absorption. Despite increasing reports of neurological complications, seizure patterns before and after bariatric surgery have not been comprehensively summarized.

METHODS

This was a systematic review conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A systematic search of PubMed, Scopus, Web of Science, and Embase was conducted through April 20, 2025. Eighty-three studies reporting seizures before and/or after bariatric surgery were included. Data on patient demographics, surgery type, seizure timing, etiology, AED adjustments, and clinical outcomes were narratively synthesized.

RESULTS

Across the included studies, patients were mostly middle-aged women undergoing sleeve gastrectomy or Roux-en-Y gastric bypass. Three outcome patterns emerged. Some patients with pre-existing epilepsy remained seizure-free postoperatively with stable AED regimens. Others experienced persistent or recurrent seizures, commonly associated with reduced postoperative absorption of valproate or phenytoin, requiring dose escalation or drug substitution. New-onset postoperative seizures occurred across both surgery types and were predominantly secondary to metabolic disturbances especially hypoglycemia, hyperammonemia, electrolyte abnormalities, or cardiac arrhythmia and typically resolved after addressing the underlying cause. AED adjustments were more frequently required after gastric bypass due to greater pharmacokinetic changes.

CONCLUSION

Seizure outcomes after bariatric surgery are variable and influenced by altered drug absorption and postoperative metabolic complications. Most patients maintain seizure control, but a subset develops breakthrough or new-onset seizures, highlighting the need for AED monitoring and careful evaluation of metabolic causes.

© 2026 The Authors.

Address: Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, Core member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.; Department of Surgery, Bielefeld University Medical School and University Hospital OWL - Campus Klinikum Lippe, Detmold, NRW, Germany.; Department of Surgical Oncology, Transplant Surgery and General Surgery, Medical University Gdansk, Gdansk, Poland.; Health Education and Improvement Wales, Wales, UK.; Bariatric Clinic, Klinikum Bielefeld - Rosenhöhe, Bielefeld, Germany.; Bielefeld University, Medical School and University Medical Center OWL, Klinikum Bielefeld-Mitte, Department of General and Visceral Surgery, Bielefeld, Germany.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.